Down-regulation of sarcolipin mRNA expression in chronic atrial fibrillation

European Journal of Clinical Investigation

Volumn 34, Issue 11, 2004, Pages 723-730

  Uemura, N ^a,b   Ohkusa, T ^c   Hamano, K ^c   Nakagome, M ^a   Hori, H ^a   Shimizu, H ^d   Matsuzaki, M ^c   Mochizuki, S ^b   Minamisawa, Susumu ^a   Ishikawa, Y ^a,e  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Arrhythmia; Calcium; Electrical remodelling; Gene expression

Indexed keywords

CALSEQUESTRIN; MESSENGER RNA; PHOSPHOLAMBAN; PROTEOLIPID; SARCOLIPIN; SODIUM CALCIUM EXCHANGE PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM HOMEOSTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; HEART ATRIUM FIBRILLATION; HEART ATRIUM PRESSURE; HEART ELECTROPHYSIOLOGY; HUMAN; MITRAL VALVE DISEASE; OPEN HEART SURGERY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINUS RHYTHM;

ADULT; AGED; ATRIAL FIBRILLATION; CALCIUM-BINDING PROTEINS; CALSEQUESTRIN; CHRONIC DISEASE; DOWN-REGULATION; FEMALE; GENE EXPRESSION; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; MITRAL VALVE STENOSIS; MUSCLE PROTEINS; MYOCARDIUM; PROTEOLIPIDS; RNA, MESSENGER; SODIUM-CALCIUM EXCHANGER;

EID: 8744318243     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2004.01422.x     Document Type: Article

References (27)

1. Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation. Time course and mechanisms. Circulation 1996;94:2968-74.
2. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995;92:1954-68.
3. Franz MR, Karasik PL, Li C, Moubarak J, Chavez M. Electrical remodeling of the human atrium: similar effects in patients with chronic atrial fibrillation and atrial flutter. J Am Coll Cardiol 1997,30:1785-92.
4. Rosen MR. Mechanisms of cardiac arrhythmias: focus on atrial fibrillation. J Gend Specif Med 2001;4:37-47.
5. Allessie MA, Boyden PA, Camm AJ, Kleber AG, Lab MJ, Legato MJ et al. Pathophysiology and prevention of atrial fibrillation. Circulation 2001;103:769-77.
6. Brundel BJ, Van Gelder IC, Henning RH, Tieleman RG, Tuinenburg AE, Wietses M et al. Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation. Circulation 2001;103:684-90.
7. Dobrev D, Ravens U. Remodeling of cardiomyocyte ion channels in human atrial fibrillation. Basic Res Cardiol 2003;98:137-48.
8. Bosch RF, Zeng X, Grammer JB, Popovic K, Mewis C, Kuhlkamp V. Ionic mechanisms of electrical remodeling in human atrial fibrillation. Cardiovasc Res 1999;44:121-31.
9. Dobrev D, Wettwer E, Kortner A, Knaut M, Schuler S, Ravens U. Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation. Cardiovasc Res 2002;54:397-404.
10. Sun H, Gaspo R, Leblanc N, Nattel S. Cellular mechanisms of atrial contractile dysfunction caused by sustained atrial tachycardia. Circulation 1998;98:719-27.
11. 2+ regulatory proteins in the atrial tissue of patients with chronic atrial fibrillation. J Am Coll Cardiol 1999;34:255-63.
12. Yamda J, Ohkusa T, Nao T, Ueyama T, Yano M, Kobayashi S et al. Up-regulation of inositol 1,4,5 trisphosphate receptor expression in atrial tissue in patients with chronic atrial fibrillation. J Am Coll Cardiol 2001;37:1111-9.
13. Kneller J, Sun H, Leblanc N, Nattel S. Remodeling of Ca(2+)- handling by atrial tachycardia: evidence for a role in loss of rate-adaptation. Cardiovasc Res 2002;54:416-26.
14. Schotten U, Greiser M, Benke D, Buerkel K, Ehrenteidt B, Stellbrink C et al. Atrial fibrillation-induced atrial contractile dysfunction: a tachycardiomyopathy of a different sort. Cardiovasc Res 2002;53:192-201.
15. Brundel BJ, van Gelder IC, Henning RH, Tuinenburg AE, Deelman LE, Tieleman RG et al. Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation. Cardiovasc Res 1999;42:443-54.
16. Lai LP, Su MJ, Lin JL, Lin FY, Tsai CH, Chen YS et al. Down-regulation of 1-type calcium channel and sarcoplasmic reticular Ca(2+)-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: an insight into the mechanism of atrial electrical remodeling. J Am Coll Cardiol 1999;33:1231-7.
17. Luo W, Grupp IL, Harrer J, Ponniah S, Grupp G, Duffy JJ et al. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation. Circ Res 1994;75:401-9.
18. Minamisawa S, Hoshijima M, Chu G, Ward CA, Frank K, Gu Y et al. Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. Cell 1999;99:313-22.
19. 2+ channels in mouse ventricular myocytes. Am J Physiol 1997;272:H606-12.
20. MacLennan DH, Asahi M, Tupling AR. The regulation of SERCA-type pumps by phospholamban and sarcolipin. Ann N Y Acad Sci 2003;986:47280.
21. Minamisawa S, Wang Y, Chen J, Ishikawa Y, Chien KR, Matsuoka R. Atrial chamber-specific expression of sarcolipin is regulated during development and hypertrophic remodeling. J Biol Chem 2003;278:9570-5.
22. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996;6:986-94.
23. 2+ uptake and impairs contractile function. J Biol Chem 2002;277:44740-6.
24. 2+-ATPases (SERCAs). J Biol Chem 2002;277:26725-8.
25. 2+-ATPaSe. J Biol Chem 1998;273:12360-9.
26. Lowes BD, Gilbert EM, Abraham WT, Minobe WA, Larrabee P, Ferguson D et al. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. N Engl J Med 2002;346:1357-65.
27. Muller-Ehmsen J, Nickel J, Zobel C, Hirsch I, Bolck B, Brixius K et al. Longer term effects of ouabain on the contractility of rat isolated cardiomyocytes and on the expression of Ca and Na regulating proteins. Basic Res Cardiol 2003;98:90-6.